Jonathan Peacock
Overview
Jonathan Peacock received an average of $2M in total compensation, including $285K in salary, at Bellerophon Therapeutics from 2014 to 2016.
Source: SEC filings on March 20, 2017 and April 27, 2016.
Related executives
We found seven more executives who work or worked at Bellerophon Therapeutics.
Fabian Tenenbaum
Bellerophon Therapeutics
Chief Executive Officer
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
Martin Dekker
Bellerophon Therapeutics